's Bulletin Board Post A Reply
my profile login | register | search | faq | forum home

»'s Bulletin Board » Hot Stocks Free for All ! » TPIV analysts say $1.50 coming! Check it out: » Post A Reply

Post A Reply
Login Name:
Message Icon: Icon 1     Icon 2     Icon 3     Icon 4     Icon 5     Icon 6     Icon 7    
Icon 8     Icon 9     Icon 10     Icon 11     Icon 12     Icon 13     Icon 14    

HTML is not enabled.
UBB Code™ is enabled.


Instant Graemlins Instant UBB Code™
Smile   Frown   Embarrassed   Big Grin   Wink   Razz  
Cool   Roll Eyes   Mad   Eek!   Confused   BadOne  
Good Luck   More Crap   Wall Bang   Were Up   Were Down    
Insert URL Hyperlink - UBB Code™   Insert Email Address - UBB Code™
Bold - UBB Code™   Italics - UBB Code™
Quote - UBB Code™   Code Tag - UBB Code™
List Start - UBB Code™   List Item - UBB Code™
List End - UBB Code™   Image - UBB Code™

What is UBB Code™?

Disable Graemlins in this post.


T O P I C     R E V I E W
flatrader  - posted
TPIV analysts say $1.50 coming! Check it out:

Tapimmune expects to sign up multiple partnerships for technology development and commercialization in large markets because “our technology has the potential to improve a variety of other technologies and approaches
in the treatment of breast cancer and other infectious diseases, says Dr. Wilson. The company, he adds, expects to become a market leader in biotechnology “as we expect our continuing research to yield a pipeline of products.

Apart from a potential to make substantial returns from their investments, investors in the company should get the satisfaction that “their money would be directed to technologies which could alleviate pain and suffering caused by both the diseases and existing treatments.”

"When Tapimmune is recognized as an immunotherapy play along with the likes of Northwest BioTherapeutics (NWBO) and ImmunoCellular Therapeutics (IMUC), the market cap of Tapimmune is expected by some analysts to hit a market cap of $100 million, or a stock price of $1.50......"

Contact Us | Message Board Home

© 1997 - 2018 All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2